Jan Friedrich

Name/ Title/Designations/Academic Rank/Brief Bio:
Jan O. Friedrich, MD, DPhil, FRCP(C)
Lecturer
BSc (Honours) Chemistry, Dalhousie University 1985
Doctor of Philosophy Physical Chemisty, Oxford University 1988
MD (magna cum laude), Harvard University 1996
Internal Medicine Residency, FRCP(C), University of Toronto 1996-2000
Critical Care Medicine Residency, University of Toronto 1999-2001

Site/Hospital:
Critical Care and Medicine Departments, St. Michael's Hospital

List of Education/ Clinical/ Research Interest:
Meta-Analytic Techniques
Renal Failure in ICU
Long-Stay ICU Patient Outcomes

List of Recent Publications:
Friedrich JO, Adhikari NKJ, Meade MO. Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis? Critical Care 2006;10:145.
Friedrich JO, Wilson G, Chant C. Long-term outcome and clinical predictors of hospital mortality in very long stay intensive care unit patients: a cohort study. Critical Care 2006;10:R59.
Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510.
Chant C, Wilson G, Friedrich JO. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy 2005;25(3):352.